2023 Q4 Form 10-Q Financial Statement

#000121390023089237 Filed on November 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $177.0K $62.00K
YoY Change 390.47%
Cost Of Revenue $200.0K
YoY Change 630.07%
Gross Profit -$23.08K $62.00K
YoY Change -365.9%
Gross Profit Margin -13.04% 100.0%
Selling, General & Admin $127.1K $309.9K
YoY Change -86.8% -13.76%
% of Gross Profit 499.81%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $127.1K $309.9K
YoY Change -86.8% -13.76%
Operating Profit -$150.2K -$247.9K
YoY Change -84.26% -31.01%
Interest Expense -$1.953M $169.4K
YoY Change -28.07% -15.43%
% of Operating Profit
Other Income/Expense, Net -$749.6K
YoY Change 274.28%
Pretax Income -$2.103M -$997.4K
YoY Change -42.68% 78.25%
Income Tax
% Of Pretax Income
Net Earnings -$2.103M -$997.4K
YoY Change -42.68% 78.25%
Net Earnings / Revenue -1188.65% -1608.77%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share -$0.11 $0.00
COMMON SHARES
Basic Shares Outstanding 40.76M shares 33.36B shares
Diluted Shares Outstanding 33.30M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.310K $3.870K
YoY Change -96.22% -95.93%
Cash & Equivalents $6.308K $3.868K
Short-Term Investments
Other Short-Term Assets $1.840K $860.00
YoY Change 113.95%
Inventory
Prepaid Expenses
Receivables $18.17K
Other Receivables $0.00 $0.00
Total Short-Term Assets $26.32K $4.727K
YoY Change -85.66% -95.03%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $26.32K $4.727K
Total Long-Term Assets $0.00 $0.00
Total Assets $26.32K $4.727K
YoY Change -85.66% -95.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.145M $952.8K
YoY Change 40.74% 128.36%
Accrued Expenses $213.7K $364.6K
YoY Change -41.71% -51.64%
Deferred Revenue
YoY Change
Short-Term Debt $470.1K $896.4K
YoY Change -29.79% 147.41%
Long-Term Debt Due $254.5K $446.7K
YoY Change -16.15% 73.69%
Total Short-Term Liabilities $4.472M $6.854M
YoY Change -23.16% 132.0%
LONG-TERM LIABILITIES
Long-Term Debt $193.2K $0.00
YoY Change -25.83% -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $193.2K $0.00
YoY Change -25.83% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.472M $6.854M
Total Long-Term Liabilities $193.2K $0.00
Total Liabilities $4.665M $6.854M
YoY Change -23.28% 110.18%
SHAREHOLDERS EQUITY
Retained Earnings -$12.99M -$12.25M
YoY Change 40.56% 119.84%
Common Stock $535.00 $333.6K
YoY Change -99.8% 52.78%
Preferred Stock
YoY Change
Treasury Stock (at cost) $773.5K $773.5K
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity -$4.639M -$6.850M
YoY Change
Total Liabilities & Shareholders Equity $26.32K $4.727K
YoY Change -85.66% -95.03%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$2.103M -$997.4K
YoY Change -42.68% 78.25%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$4.396M -$46.58K
YoY Change 2152.78% -83.78%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.398M -27.30K
YoY Change 1556.52% -128.0%
NET CHANGE
Cash From Operating Activities -4.396M -46.58K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 4.398M -27.30K
Net Change In Cash 2.440K -73.88K
YoY Change -96.61% -61.06%
FREE CASH FLOW
Cash From Operating Activities -$4.396M -$46.58K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022Q3 bomo Initial Recognition Of Derivative Liability
InitialRecognitionOfDerivativeLiability
usd
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33300997 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54624
dei Entity Registrant Name
EntityRegistrantName
bowmo, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-4144571
dei Entity Address Address Line1
EntityAddressAddressLine1
99 Wall Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 891
dei Entity Address City Or Town
EntityAddressCityOrTown
New York City
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10005
dei City Area Code
CityAreaCode
(212)
dei Local Phone Number
LocalPhoneNumber
398-0002
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common stock
dei Trading Symbol
TradingSymbol
BOMO
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40763149 shares
CY2023Q3 us-gaap Cash
Cash
3868 usd
CY2022Q4 us-gaap Cash
Cash
167103 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15542 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
859 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
858 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
4727 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
183503 usd
CY2023Q3 us-gaap Assets
Assets
4727 usd
CY2022Q4 us-gaap Assets
Assets
183503 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
952832 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
813378 usd
CY2023Q3 bomo Accrued Expenses Current
AccruedExpensesCurrent
200000 usd
CY2022Q4 bomo Accrued Expenses Current
AccruedExpensesCurrent
200286 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
364597 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
366622 usd
CY2023Q3 bomo Accrued Officer Compensation
AccruedOfficerCompensation
1398500 usd
CY2022Q4 bomo Accrued Officer Compensation
AccruedOfficerCompensation
1074361 usd
CY2023Q3 us-gaap Loans Payable Current
LoansPayableCurrent
192222 usd
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
113006 usd
CY2023Q3 bomo Loan Payable Related Party
LoanPayableRelatedParty
254500 usd
CY2022Q4 bomo Loan Payable Related Party
LoanPayableRelatedParty
190500 usd
CY2023Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
896425 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
669581 usd
CY2023Q3 bomo Preferred Stocks Redemption Premium
PreferredStocksRedemptionPremium
205684 usd
CY2022Q4 bomo Preferred Stocks Redemption Premium
PreferredStocksRedemptionPremium
219687 usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2389588 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2172250 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6854348 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5819671 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
260494 usd
CY2023Q3 us-gaap Liabilities
Liabilities
6854348 usd
CY2022Q4 us-gaap Liabilities
Liabilities
6080165 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
333609842 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
333609842 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
270497364 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
270497364 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
333610 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
270497 usd
CY2023Q3 bomo Common Stock To Be Issued
CommonStockToBeIssued
25 usd
CY2022Q4 bomo Common Stock To Be Issued
CommonStockToBeIssued
25 usd
CY2023Q3 bomo Common Stock Value Yet To Be Issued
CommonStockValueYetToBeIssued
26 usd
CY2022Q4 bomo Common Stock Value Yet To Be Issued
CommonStockValueYetToBeIssued
26 usd
CY2023Q3 bomo Treasury Stock Share
TreasuryStockShare
7735 shares
CY2022Q4 bomo Treasury Stock Share
TreasuryStockShare
7735 shares
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
773500 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
773500 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5593322 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4963869 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12254297 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10608772 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-6849621 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5896662 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4727 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
183503 usd
us-gaap Revenues
Revenues
66476 usd
us-gaap Revenues
Revenues
149848 usd
CY2023Q3 us-gaap Revenues
Revenues
62000 usd
us-gaap Cost Of Revenue
CostOfRevenue
48470 usd
us-gaap Gross Profit
GrossProfit
66476 usd
us-gaap Gross Profit
GrossProfit
101378 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
62000 usd
us-gaap Salaries And Wages
SalariesAndWages
431421 usd
us-gaap Salaries And Wages
SalariesAndWages
301660 usd
CY2023Q3 us-gaap Salaries And Wages
SalariesAndWages
209303 usd
CY2022Q3 us-gaap Salaries And Wages
SalariesAndWages
98375 usd
bomo Consulting Expense
ConsultingExpense
90000 usd
bomo Consulting Expense
ConsultingExpense
1486514 usd
CY2023Q3 bomo Consulting Expense
ConsultingExpense
30000 usd
CY2022Q3 bomo Consulting Expense
ConsultingExpense
75000 usd
us-gaap Professional Fees
ProfessionalFees
166884 usd
us-gaap Professional Fees
ProfessionalFees
247837 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
3415 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
117119 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
174584 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
123735 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
67163 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
68820 usd
us-gaap Operating Expenses
OperatingExpenses
862889 usd
us-gaap Operating Expenses
OperatingExpenses
2159746 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
309881 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
359314 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-796413 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2058368 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-247881 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-359314 usd
us-gaap Interest Expense
InterestExpense
666774 usd
us-gaap Interest Expense
InterestExpense
243429 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
169369 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
200269 usd
us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
27856 usd
bomo Initial Recognition Of Derivative Liability
InitialRecognitionOfDerivativeLiability
32429 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
149909 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1545 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-580189 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-849112 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-217118 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-749558 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-200269 usd
us-gaap Net Income Loss
NetIncomeLoss
-1645525 usd
us-gaap Net Income Loss
NetIncomeLoss
-2275486 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-997439 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-559583 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31260512 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8488816 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33300997 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18514334 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-842294 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-64062 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-906356 usd
CY2022Q2 bomo Recapitalization At Reverse Merger
RecapitalizationAtReverseMerger
-3082418 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
306220 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
599119 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1364847 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1651841 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-3370429 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
738880 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
24963 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-559583 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-3166169 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5896662 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
28314 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
14995 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
418587 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
617642 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4817124 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
28314 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
9994 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
106059 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1265728 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-5938485 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
29257 usd
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
57046 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-997439 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-6849621 usd
us-gaap Net Income Loss
NetIncomeLoss
-1645525 usd
us-gaap Net Income Loss
NetIncomeLoss
-2275486 usd
bomo Reconciliation Of Debt Balances
ReconciliationOfDebtBalances
111000 usd
bomo Reconciliation Of Debt Balances
ReconciliationOfDebtBalances
60717 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
149910 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1545 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
418163 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
109236 usd
us-gaap Share Based Compensation
ShareBasedCompensation
265802 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1488604 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
27856 usd
us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
23905 usd
us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
90246 usd
bomo Initial Derivative Expense
InitialDerivativeExpense
32429 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15543 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-37638 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
139454 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-286 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
30511 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
73485 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
324139 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
22565 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3108 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-134957 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-422414 usd
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
517 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
517 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-117278 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
269100 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
89000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
247500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-28278 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
516600 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-163235 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
94703 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167103 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
382 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3868 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95085 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-80257 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-528100 usd
CY2023Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1:100
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Use of Estimates</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
896425 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
669581 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Concentrations of Credit Risk</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.</p>
us-gaap Stockholders Equity Other Shares
StockholdersEquityOtherShares
63112489 shares
CY2023Q3 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
53914411 shares
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
62000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
686476 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
149848 usd
us-gaap Accounts Receivable Sale
AccountsReceivableSale
0 usd
CY2022Q4 us-gaap Loans Receivable Basis Spread On Variable Rate
LoansReceivableBasisSpreadOnVariableRate
1 pure
bomo Revenues Percentage
RevenuesPercentage
1 pure
CY2022Q3 bomo Revenues Percentage
RevenuesPercentage
0.10 pure
CY2023Q3 us-gaap Other Loans Payable
OtherLoansPayable
564000 usd
CY2022Q4 us-gaap Other Loans Payable
OtherLoansPayable
564000 usd
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
27856 usd
CY2023Q3 us-gaap Retained Earnings Appropriated
RetainedEarningsAppropriated
12230000 usd
CY2022Q4 bomo Asset Acquisition Additional Equity Interest Issued And Issuable
AssetAcquisitionAdditionalEquityInterestIssuedAndIssuable
1000000 shares
CY2022 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
197370 usd
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
21862 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
15279 usd
CY2023Q3 bomo Debt Instrument Carrying Amounts
DebtInstrumentCarryingAmounts
976681 usd
CY2022Q4 bomo Debt Instrument Carrying Amounts
DebtInstrumentCarryingAmounts
1197681 usd
us-gaap Premiums Earned Net
PremiumsEarnedNet
976681 usd
CY2023Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
205684 usd
CY2021Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
110992 usd
CY2022 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
2718645 usd
CY2022 bomo Derivative Liability Transfer To Put Premium
DerivativeLiabilityTransferToPutPremium
-112537 usd
CY2022 bomo Derivative Gain Loss On Derivative Fair Value
DerivativeGainLossOnDerivativeFairValue
-544850 usd
CY2022Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
2172250 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
129929 usd
bomo Derivative Liability Transfer To Put Premium
DerivativeLiabilityTransferToPutPremium
-62500 usd
bomo Derivative Gain Loss On Derivative Fair Value
DerivativeGainLossOnDerivativeFairValue
149909 usd
CY2023Q3 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
2389588 usd
us-gaap Common Stock Voting Rights
CommonStockVotingRights
one
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
333609842 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
270497364 shares
CY2023Q3 us-gaap Stockholders Equity Other Shares
StockholdersEquityOtherShares
9198068 shares
CY2023Q3 bomo Debt Instrument Face Value
DebtInstrumentFaceValue
375000 usd
us-gaap Debt Instrument Increase Decrease Other Net
DebtInstrumentIncreaseDecreaseOtherNet
29152 usd
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
20490 usd
CY2023Q3 bomo Total Debt Current
TotalDebtCurrent
424642 usd
CY2022 bomo Class Of Warrants Or Rights Warrants Issued During Period
ClassOfWarrantsOrRightsWarrantsIssuedDuringPeriod
56160000 shares
CY2022 bomo Warrant To Purchase Common Shares
WarrantToPurchaseCommonShares
56160000 shares
bomo Fair Value Of Warrants
FairValueOfWarrants
619675 usd
CY2023Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
61160000 shares
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P5Y10M9D
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.0001
CY2023Q3 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
1
bomo Percentage Of Conversion Price
PercentageOfConversionPrice
0.61 pure
bomo Percentage Of Common Stock Issued And Outstanding
PercentageOfCommonStockIssuedAndOutstanding
0.12 pure
CY2022 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
40875 usd
CY2021 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
50500 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
524315 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
474884 usd
bomo Amount Of Indebtedness
AmountOfIndebtedness
1200000 usd
CY2017Q1 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
27084 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2023Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
usd
CY2023Q3 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
usd
bomo Initial Recognition Of Derivative Liability
InitialRecognitionOfDerivativeLiability
usd
CY2023Q3 bomo Initial Recognition Of Derivative Liability
InitialRecognitionOfDerivativeLiability
usd
CY2022Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
usd
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18514334 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31260512 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8488816 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
bomo Initial Derivative Expense
InitialDerivativeExpense
usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
usd
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001381871

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001213900-23-089237-index-headers.html Edgar Link pending
0001213900-23-089237-index.html Edgar Link pending
0001213900-23-089237.txt Edgar Link pending
0001213900-23-089237-xbrl.zip Edgar Link pending
bomo-20230930.xsd Edgar Link pending
f10q0923ex31_bowmoinc.htm Edgar Link pending
f10q0923ex32_bowmoinc.htm Edgar Link pending
bomo-20230930_cal.xml Edgar Link unprocessable
bomo-20230930_lab.xml Edgar Link unprocessable
bomo-20230930_def.xml Edgar Link unprocessable
bomo-20230930_pre.xml Edgar Link unprocessable
f10q0923_bowmoinc.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
f10q0923_bowmoinc_htm.xml Edgar Link completed
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending